Tevogen Bio Holdings (TVGN) Net Cash Flow (QoQ) (2022 - 2026)
Tevogen Bio Holdings (TVGN) Net Cash Flow (QoQ) (2022 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
| 10 |
Tevogen Bio Holdings |
182.04 Mn |
181.35 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
133.29% |
| Dec 31, 2025 |
-219.44% |
| Sep 30, 2025 |
127.28% |
| Jun 30, 2025 |
-286.39% |
| Mar 31, 2025 |
166.04% |
| Dec 31, 2024 |
-187.65% |
| Sep 30, 2024 |
754.92% |
| Jun 30, 2024 |
-168.74% |
| Mar 31, 2024 |
117.08% |
| Dec 31, 2023 |
-82.85% |
| Sep 30, 2023 |
61.67% |
| Jun 30, 2023 |
-1,267.95% |
| Mar 31, 2023 |
1,469.78% |
| Dec 31, 2022 |
67.46% |
| Sep 30, 2022 |
7.20% |
| Jun 30, 2022 |
59.39% |
